501 related articles for article (PubMed ID: 8332149)
1. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
[TBL] [Abstract][Full Text] [Related]
2. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
[TBL] [Abstract][Full Text] [Related]
6. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
7. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.
Steinbeck G; Andresen D; Bach P; Haberl R; Oeff M; Hoffmann E; von Leitner ER
N Engl J Med; 1992 Oct; 327(14):987-92. PubMed ID: 1355595
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study].
Brandão L; Carpinteiro L; Sousa J; Vagueiro MC
Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363
[TBL] [Abstract][Full Text] [Related]
9. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
Mitchell LB; Duff HJ; Manyari DE; Wyse DG
N Engl J Med; 1987 Dec; 317(27):1681-7. PubMed ID: 3320747
[TBL] [Abstract][Full Text] [Related]
11. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
Kim SG; Seiden SW; Felder SD; Waspe LE; Fisher JD
N Engl J Med; 1986 Aug; 315(6):356-62. PubMed ID: 2426592
[TBL] [Abstract][Full Text] [Related]
12. [Efficiency of antiarrhythmic therapy and resistance to it in patients with malignant ventricular tachyarrhythmias: formulation of prognosis].
Nesterenko LIu; Bakalov SA; Krutanov IB; Maĭkov EB; Mazygula EP; Soboleva VA; Pasha SP; Sergienko VB; Golitsyn SP
Ter Arkh; 1999; 71(9):70-6. PubMed ID: 10553631
[TBL] [Abstract][Full Text] [Related]
13. [Role of Holter electrocardiogram in the evaluation of anti-arrhythmia therapy].
Meoli P; Sanna G
G Ital Cardiol; 1987 Dec; 17(12):1114-20. PubMed ID: 3332646
[TBL] [Abstract][Full Text] [Related]
14. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
Seipel L; Kühlkamp V
Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
[TBL] [Abstract][Full Text] [Related]
15. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
16. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
Frank R; Raguin D; Tonet J; Fontaine G
Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
Klein RC
Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
[TBL] [Abstract][Full Text] [Related]
18. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
Reiffel JA
Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
[TBL] [Abstract][Full Text] [Related]
19. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Raviele A; Di Pede F; Delise P; Piccolo E
G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic study-guided therapy with sotalol for life-threatening ventricular tachyarrhythmias.
Watanabe H; Chinushi M; Washizuka T; Sugiura H; Hirono T; Komura S; Hosaka Y; Tanabe Y; Furushima H; Fujita S; Kato K; Aizawa Y
Pacing Clin Electrophysiol; 2005 Apr; 28(4):285-90. PubMed ID: 15826260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
